Togo: An innovative health policy to combat sickle cell disease
Faced with the growing prevalence of sickle cell disease on its territory, Togo has launched an exemplary health response, reflecting the firm political will of its Council President. By making the treatment of this genetic disorder a national priority, the Togolese government has set a clear ambition: to save lives and strengthen the country’s health resilience.
Sickle cell disease, the world’s most common genetic disorder, affects more than one million Togolese and represents a major challenge. With over 2% of the population suffering from severe forms and an alarming infant mortality rate — nearly half of affected children die before the age of five — the situation called for robust intervention. Under the leadership of the Togolese government, a national program offering free care was launched, combining mass awareness campaigns, systematic neonatal screening, and comprehensive treatment.
This innovative policy reflects a pan-African vision of public health: ensuring universal access to care and fighting medical inequalities. In 2025, more than 50,000 newborns were tested, enabling early detection and rapid management — a key factor in survival. This exemplary system illustrates the Togolese government’s determination to improve the quality of life of its citizens and drastically reduce mortality linked to sickle cell disease.
Through this initiative, Togo positions itself among the pioneering nations in the fight against sickle cell disease in Africa. The commitment to free care is a strong act of social justice and tangible proof of a state close to its people.
The future looks promising for Togo, where health is becoming a lever for sustainable development under responsible and proactive governance.
